Similarly, high serum hepcidin levels have been documented in patients with breast cancer as compared to normal subjects and patients with benign breast diseases [19] as well as in patients with metastatic gastric cancer, patients with non-small cell lung cancer and patients with multiple myeloma [20,21,22]. The gene discussed is HAMP; the disease is breast fibrocystic disease.